Amniotic fluid-derived stem cells for bone tissue engineering

Jaehyun Kim, Sookwon Ryu, Young Min Ju, James J. Yoo, Anthony Atala

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Implantation of bone substitute materials and autologous bone grafting have been used for the treatment of extensive bone defects. Recent advances in tissue engineering have led to integration of viable, biological bone grafts composed of osteogenic cells proliferating within three-dimensional (3D) scaffolds. Not only could these novel grafts be used for implantation, but also they could serve in basic and translational studies of bone development, disease, and drug discovery. The ability to isolate human cells, expand them to a large density, and differentiate them into bone-forming cells remains critical to the success of human bone graft engineering. This chapter will focus on the characteristics and limitations of human amniotic stem cells and their application in bone tissue engineering. Stem cells have proved to be an ideal source of cells for bone tissue engineering due to their ability to differentiate into osteogenic lineages. Recently, amniotic fluid-derived stem (AFS) cells that are isolated from amniotic fluid removed by amniocentesis have been identified as a novel stem cell source. The proliferative potential of these cells, along with their anti-immunogenic and non-tumorigenic properties, make them an ideal therapeutic candidate for bone tissue regeneration without ethical issues. In this chapter, the current knowledge of AFS cell isolation, characterization, and osteogenic differentiation, as well as tissue engineering approaches for the use of these cells in bone regeneration, is discussed.

Original languageEnglish (US)
Title of host publicationPerinatal Stem Cells
PublisherSpringer New York
Pages107-114
Number of pages8
Volume9781493911189
ISBN (Print)9781493911189, 1493911171, 9781493911172
DOIs
StatePublished - Apr 1 2014
Externally publishedYes

Fingerprint

Amniotic Fluid
Tissue Engineering
Stem cells
Tissue engineering
Bone
Stem Cells
Bone and Bones
Fluids
Bone Regeneration
Grafts
Transplants
Bone Substitutes
Amniocentesis
Bone Transplantation
Cell Separation
Bone Diseases
Bone Development
Drug Discovery
Ethics
Tissue regeneration

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Kim, J., Ryu, S., Ju, Y. M., Yoo, J. J., & Atala, A. (2014). Amniotic fluid-derived stem cells for bone tissue engineering. In Perinatal Stem Cells (Vol. 9781493911189, pp. 107-114). Springer New York. https://doi.org/10.1007/978-1-4939-1118-9_10

Amniotic fluid-derived stem cells for bone tissue engineering. / Kim, Jaehyun; Ryu, Sookwon; Ju, Young Min; Yoo, James J.; Atala, Anthony.

Perinatal Stem Cells. Vol. 9781493911189 Springer New York, 2014. p. 107-114.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kim, J, Ryu, S, Ju, YM, Yoo, JJ & Atala, A 2014, Amniotic fluid-derived stem cells for bone tissue engineering. in Perinatal Stem Cells. vol. 9781493911189, Springer New York, pp. 107-114. https://doi.org/10.1007/978-1-4939-1118-9_10
Kim J, Ryu S, Ju YM, Yoo JJ, Atala A. Amniotic fluid-derived stem cells for bone tissue engineering. In Perinatal Stem Cells. Vol. 9781493911189. Springer New York. 2014. p. 107-114 https://doi.org/10.1007/978-1-4939-1118-9_10
Kim, Jaehyun ; Ryu, Sookwon ; Ju, Young Min ; Yoo, James J. ; Atala, Anthony. / Amniotic fluid-derived stem cells for bone tissue engineering. Perinatal Stem Cells. Vol. 9781493911189 Springer New York, 2014. pp. 107-114
@inbook{199d5f6e8ba74d52b835f34ec1f012cc,
title = "Amniotic fluid-derived stem cells for bone tissue engineering",
abstract = "Implantation of bone substitute materials and autologous bone grafting have been used for the treatment of extensive bone defects. Recent advances in tissue engineering have led to integration of viable, biological bone grafts composed of osteogenic cells proliferating within three-dimensional (3D) scaffolds. Not only could these novel grafts be used for implantation, but also they could serve in basic and translational studies of bone development, disease, and drug discovery. The ability to isolate human cells, expand them to a large density, and differentiate them into bone-forming cells remains critical to the success of human bone graft engineering. This chapter will focus on the characteristics and limitations of human amniotic stem cells and their application in bone tissue engineering. Stem cells have proved to be an ideal source of cells for bone tissue engineering due to their ability to differentiate into osteogenic lineages. Recently, amniotic fluid-derived stem (AFS) cells that are isolated from amniotic fluid removed by amniocentesis have been identified as a novel stem cell source. The proliferative potential of these cells, along with their anti-immunogenic and non-tumorigenic properties, make them an ideal therapeutic candidate for bone tissue regeneration without ethical issues. In this chapter, the current knowledge of AFS cell isolation, characterization, and osteogenic differentiation, as well as tissue engineering approaches for the use of these cells in bone regeneration, is discussed.",
author = "Jaehyun Kim and Sookwon Ryu and Ju, {Young Min} and Yoo, {James J.} and Anthony Atala",
year = "2014",
month = "4",
day = "1",
doi = "10.1007/978-1-4939-1118-9_10",
language = "English (US)",
isbn = "9781493911189",
volume = "9781493911189",
pages = "107--114",
booktitle = "Perinatal Stem Cells",
publisher = "Springer New York",

}

TY - CHAP

T1 - Amniotic fluid-derived stem cells for bone tissue engineering

AU - Kim, Jaehyun

AU - Ryu, Sookwon

AU - Ju, Young Min

AU - Yoo, James J.

AU - Atala, Anthony

PY - 2014/4/1

Y1 - 2014/4/1

N2 - Implantation of bone substitute materials and autologous bone grafting have been used for the treatment of extensive bone defects. Recent advances in tissue engineering have led to integration of viable, biological bone grafts composed of osteogenic cells proliferating within three-dimensional (3D) scaffolds. Not only could these novel grafts be used for implantation, but also they could serve in basic and translational studies of bone development, disease, and drug discovery. The ability to isolate human cells, expand them to a large density, and differentiate them into bone-forming cells remains critical to the success of human bone graft engineering. This chapter will focus on the characteristics and limitations of human amniotic stem cells and their application in bone tissue engineering. Stem cells have proved to be an ideal source of cells for bone tissue engineering due to their ability to differentiate into osteogenic lineages. Recently, amniotic fluid-derived stem (AFS) cells that are isolated from amniotic fluid removed by amniocentesis have been identified as a novel stem cell source. The proliferative potential of these cells, along with their anti-immunogenic and non-tumorigenic properties, make them an ideal therapeutic candidate for bone tissue regeneration without ethical issues. In this chapter, the current knowledge of AFS cell isolation, characterization, and osteogenic differentiation, as well as tissue engineering approaches for the use of these cells in bone regeneration, is discussed.

AB - Implantation of bone substitute materials and autologous bone grafting have been used for the treatment of extensive bone defects. Recent advances in tissue engineering have led to integration of viable, biological bone grafts composed of osteogenic cells proliferating within three-dimensional (3D) scaffolds. Not only could these novel grafts be used for implantation, but also they could serve in basic and translational studies of bone development, disease, and drug discovery. The ability to isolate human cells, expand them to a large density, and differentiate them into bone-forming cells remains critical to the success of human bone graft engineering. This chapter will focus on the characteristics and limitations of human amniotic stem cells and their application in bone tissue engineering. Stem cells have proved to be an ideal source of cells for bone tissue engineering due to their ability to differentiate into osteogenic lineages. Recently, amniotic fluid-derived stem (AFS) cells that are isolated from amniotic fluid removed by amniocentesis have been identified as a novel stem cell source. The proliferative potential of these cells, along with their anti-immunogenic and non-tumorigenic properties, make them an ideal therapeutic candidate for bone tissue regeneration without ethical issues. In this chapter, the current knowledge of AFS cell isolation, characterization, and osteogenic differentiation, as well as tissue engineering approaches for the use of these cells in bone regeneration, is discussed.

UR - http://www.scopus.com/inward/record.url?scp=84929744606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929744606&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-1118-9_10

DO - 10.1007/978-1-4939-1118-9_10

M3 - Chapter

SN - 9781493911189

SN - 1493911171

SN - 9781493911172

VL - 9781493911189

SP - 107

EP - 114

BT - Perinatal Stem Cells

PB - Springer New York

ER -